Company Filing History:
Years Active: 2010-2012
Title: Min Wang: Innovator in Prostate Cancer Research
Introduction
Min Wang is a prominent inventor based in Gulph Mills, PA (US). He has made significant contributions to the field of cancer research, particularly in the detection and treatment of prostate cancer. With a total of 5 patents, his work focuses on innovative methods and compositions that leverage advanced technologies.
Latest Patents
Min Wang's latest patents include groundbreaking inventions related to prostate cancer. One of his notable patents is centered on compositions, methods, and kits based on DNA microarray proteomics platforms. This invention involves novel nucleic acids encoding a mammalian PCADM-1 gene, which is expressed at increased levels in various diseases, including prostate cancer. The patent outlines methods for detecting and treating prostate cancer by modulating or detecting PCADM-1 expression and the activity of the PCADM-1 polypeptide. Additionally, it introduces novel assays for identifying DNA-binding proteins and the specific double-stranded oligonucleotide sequences that bind to them. Furthermore, the invention discusses DNAZYMs or DNA enzymes that target PCADM-1 mRNA to inhibit its gene expression, ultimately aiming to destroy tumor cells and tissue.
Career Highlights
Min Wang is affiliated with Drexel University, where he continues to advance his research in cancer biology. His work has garnered attention for its potential to improve diagnostic and therapeutic strategies for prostate cancer.
Collaborations
Some of Min Wang's notable coworkers include Mark Stearns and Youji Hu, who contribute to his research endeavors and collaborative projects.
Conclusion
Min Wang's innovative work in prostate cancer research exemplifies the impact of scientific advancements on healthcare. His patents reflect a commitment to developing effective methods for cancer detection and treatment, showcasing the importance of innovation in the medical field.